Stock Market MeltUp Scenario Could Drive SP 500 to 8000 Analysts Suggest Nvidia and Leading Asian Chipmakers Ride the AI Surge SP 500 Edges Higher as Healthcare and Tech Rally Utilities Drag AsiaPacific Markets Climb as Investors Weigh USIran Diplomacy and Oil Price Volatility Telangana Heatwave Crisis 16 Deaths Trigger 4 Lakh ExGratia Economic Impact Under Scrutiny SNOW Q1 2026 Earnings EPS Beat But Stock Slips on Mixed Signals LVWR Q1 2026 Earnings Net Loss of 009 Per Share No Revenue Disclosed Stock Declines PRLD Q1 2026 Earnings EPS Beats Estimates Stock Dips Despite Narrower Loss CODX Q1 2026 Earnings EPS Falls Short of Estimates Stock Surges on Speculative Optimism Rockwell Medical Q1 2026 Earnings Wider Loss Stock Declines as Revenue Details Linger Hoth Therapeutics Holds Steady at 136 as Stock Consolidates Near Support Bath Body Works BBWI Holds Steady Near 1773 as Traders Eye Key Support and Resistance Levels Shoulder Innovations Inc SI Consolidates Near Key Support Level After Flat Trading Day Pimco Municipal Income Fund II PML Holds Steady at 743 Amid Tight Trading Range Plug Power PLUG Rises 217 as Green Hydrogen Sector Finds Its Footing VinFast Auto Warrants VFSWW Climb 26 as Price Hovers Between Support and Resistance Transportation Sector Emerges as AI Play and Iran Peace Deal Beneficiary Market Breakout Suggests VREX Q1 2026 Earnings EPS Slightly Misses Estimates Stock Declines WSJ Fitness App Investigation Flexibility Gains vs Injury Risk GPCR Q1 2026 Earnings Smaller Loss Than Expected as Pipeline Advances Q32 Bio Q1 2026 Earnings Narrowed Loss Exceeds Expectations Stock Rises CRNC Q1 2026 Earnings EPS Beats Estimates Amidst Modest Stock Uptick Hoyne Bancorp Inc Q1 2026 Earnings Narrowing Loss and Stock Resilience Amid Quiet Quarter ELTX Q1 2026 Earnings EPS Misses Estimates as ClinicalStage Biotech Advances Pipeline MNPR Q1 2026 Earnings Surprise EPS Beat in PreRevenue Biotech MTD Q1 2026 Earnings EPS Surpasses Consensus by 137 April Jobs Report Preview Labor Market Cooling But Stable Economists Say Milestone Pharmaceuticals MIST Q1 2026 Earnings EPS Miss Deepens as ClinicalStage Biotech Navigates Development Path Anixa Biosciences ANIX Edges Higher Tests Key Support Zone